Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: A Report from the Center for International Blood and Marrow Transplant Research

Authors:

Abstract
No abstract available
Funding Information
  • Health Service Grant/Cooperative Agreement (U24-CA76518)
  • National Cancer Institute (NCI)
  • National Heart, Lung and Blood Institute (NHLBI)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • NHLBI and NCI (5U01HL069294)
  • Health Resources and Services Administration (HRSA/DHHS) (N00014-06-1-0704)
  • Office of Naval Research (N00014-08-1-0058)
  • Allos, Inc.
  • Amgen, Inc.
  • Angioblast
  • Anonymous donation to the Medical College of Wisconsin
  • Ariad; Be the Match Foundation
  • Blue Cross and Blue Shield Association
  • Buchanan Family Foundation
  • CaridianBCT
  • Celgene Corporation
  • CellGenix, GmbH
  • Children's Leukemia Research Association
  • Fresenius-Biotech North America, Inc.
  • Gamida Cell Teva Joint Venture Ltd.
  • Genentech, Inc.
  • Genzyme Corporation
  • GlaxoSmithKline
  • HistoGenetics, Inc.
  • Kiadis Pharma
  • Leukemia & Lymphoma Society
  • Medical College of Wisconsin
  • Merck & Co, Inc.
  • Millennium: The Takeda Oncology Co.
  • Milliman USA, Inc.
  • Miltenyi Biotec, Inc.
  • National Marrow Donor Program
  • Optum Healthcare Solutions, Inc.
  • Osiris Therapeutics, Inc.
  • Otsuka America Pharmaceutical, Inc.
  • RemedyMD
  • Sanofi
  • Seattle Genetics
  • Sigma-Tau Pharmaceuticals
  • Soligenix, Inc.
  • StemCyte, A Global Cord Blood Therapeutics Co.
  • Stemsoft Software, Inc.
  • Swedish Orphan Biovitrum
  • Tarix Pharmaceuticals
  • Teva Neuroscience, Inc.
  • THERAKOS, Inc.
  • Wellpoint, Inc

This publication has 13 references indexed in Scilit: